How to Treat Patients with Chronic Spontaneous Urticaria with Omalizumab: Questions and Answers.

The Journal of Allergy and Clinical Immunology. in Practice
Murat TürkMarcus Maurer

Abstract

Omalizumab is an effective treatment for patients with chronic spontaneous urticaria (CSU). In routine clinical practice, physicians often face complex cases of CSU and need to decide whether patients are suitable for omalizumab treatment and how to manage this therapy. Here, we provide evidence and experience-based answers to the most common and important questions on omalizumab treatment of CSU. At 4 large urticaria centers, questions on the use of omalizumab in the treatment of patients with CSU were collected and then ranked by frequency and importance and grouped into top 5 domains using an interactive consensus approach. We suggest that omalizumab can be used to treat patients with CSU with any of the 3 CSU phenotypes (wheals only, angioedema only, wheals and angioedema), with comorbid chronic inducible urticaria, with cancer, who receive other biologics or cyclosporine, or who are pregnant or want to become pregnant, or are breast-feeding. Omalizumab treatment should be started with 300 mg every 4 weeks, monitored with validated patient-reported outcome measures, and maintained, in responders, until remission of CSU. Finally, partial responders or non responders can benefit from omalizumab updosing or adding or switching...Continue Reading

References

Oct 13, 2007·The Journal of Allergy and Clinical Immunology·Mark F SandsStanley A Schwartz
Sep 9, 2008·The Journal of Allergy and Clinical Immunology·Allen P KaplanRobert K Zeldin
Feb 18, 2012·The Journal of Allergy and Clinical Immunology·Ronit Confino-CohenArnon Goldberg
Mar 1, 2012·The Journal of Allergy and Clinical Immunology·William BusseJanice Canvin
Feb 26, 2013·The New England Journal of Medicine·Marcus MaurerThomas Casale
Apr 3, 2013·Acta Dermato-venereologica·Helene PiteUlrike Raap
Apr 4, 2013·International Archives of Allergy and Immunology·Rafael Rabelo-FilardiRégis A Campos
Apr 12, 2013·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Antonie von WebskyKristine Breuer
Jul 3, 2013·The Journal of Allergy and Clinical Immunology·Allen KaplanKarin Rosén
Oct 10, 2013·The British Journal of Dermatology·R Vieira Dos SantosM Maurer
Feb 14, 2014·The Journal of Allergy and Clinical Immunology·Karsten WellerMarcus Maurer
Mar 25, 2014·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Allen P Kaplan
Apr 1, 2014·The Journal of Allergy and Clinical Immunology·Aidan LongStanley J Szefler
May 9, 2014·Asia Pacific Allergy·Ayse Bilge Ozturk, Emek Kocaturk
Jun 21, 2014·The Journal of Allergy and Clinical Immunology·Tse Wen ChangMarcus Maurer
Nov 18, 2014·International Archives of Allergy and Immunology·Timothy J CraigIsabelle Boccon-Gibod
Nov 29, 2014·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·M FerrerA Valero
Dec 3, 2014·The Journal of Allergy and Clinical Immunology·Jennifer NamazyElizabeth B Andrews
Jan 9, 2015·Expert Review of Clinical Immunology·Torsten Zuberbier, Marcus Maurer
Feb 24, 2015·Case Reports in Medicine·Misbah Nasheela Ghazanfar, Simon Francis Thomsen
Mar 10, 2015·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Julián AzofraMarta Ferrer
May 28, 2015·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Elena NetchiporoukMoshe Ben-Shoshan
Jun 7, 2015·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Chiara TontiniLeonardo Antonicelli
Jun 10, 2015·The Journal of Allergy and Clinical Immunology. in Practice·Thomas B CasaleKarin Rosén
Jun 22, 2015·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Daniel HarDavid A Khan
Jul 22, 2015·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Sinisa SavicClive Grattan
Oct 21, 2015·The Journal of Allergy and Clinical Immunology·Allen KaplanJames L Zazzali
Dec 15, 2015·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Luis Felipe EnsinaDirceu Solé
Apr 5, 2016·The Journal of Allergy and Clinical Immunology·Zuo-Tao ZhaoMarcus Maurer
Jun 1, 2016·The Korean Journal of Internal Medicine·Won-Sun ChoiYoung-Min Ye
Jul 18, 2016·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·James L ZazzaliKarin E Rosén
Nov 9, 2016·Journal of Clinical Immunology·Charles FaisantLaurence Bouillet
Nov 14, 2016·The Journal of Allergy and Clinical Immunology·Janine GerickeMarcus Maurer
Nov 22, 2016·Journal of the European Academy of Dermatology and Venereology : JEADV·M González-MedinaA Giménez-Arnau
Nov 25, 2016·European Journal of Dermatology : EJD·Christian VestergaardAna Giménez-Arnau

❮ Previous
Next ❯

Citations

Dec 12, 2020·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·Andriana I PapaioannouStelios Loukides
Apr 17, 2020·The Journal of Allergy and Clinical Immunology. in Practice·Sarbjit SainiMarcus Maurer
Mar 1, 2020·The Journal of Allergy and Clinical Immunology. in Practice·Jorge SánchezRicardo Cardona
Feb 26, 2021·ImmunoTargets and Therapy·Bettina Wedi, Stephan Traidl
Mar 2, 2021·Allergo Journal International·Andrea BauerMarcus Maurer
Mar 10, 2021·The Journal of Allergy and Clinical Immunology. in Practice·Marcus MaurerAllen P Kaplan
Apr 3, 2021·Frontiers in Immunology·Shuang-Lu LiaoMarcus Maurer
Jun 12, 2021·The Journal of Allergy and Clinical Immunology. in Practice·David A KhanEmel Aygören-Pürsün
Jun 23, 2021·The Australasian Journal of Dermatology·Andac SalmanOzlem Apti Sengun

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
Maria Rita BongiornoGiuseppe Valenti
Journal of the European Academy of Dermatology and Venereology : JEADV
M González-MedinaAna M Giménez-Arnau
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
Renee Koski, Katelin K Kennedy
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
Miles Weinberger
© 2021 Meta ULC. All rights reserved